LeonaBio (LONA) Accumulated Expenses (2019 - 2026)

LeonaBio (LONA) has 8 years of Accumulated Expenses data on file, last reported at $4.4 million in Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 5.36% year-over-year to $4.4 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 5.36% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, down 84.29% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $4.4 million, up from $1.9 million in the prior quarter.
• Over the last five years, Accumulated Expenses for LONA reached as high as $12.4 million in Q4 2024 and fell as low as $1.9 million in Q4 2025.
• Historically, Accumulated Expenses has averaged $5.4 million across 5 years, with a median of $4.4 million in 2026.
• Across the five-year window, Accumulated Expenses soared 1519.87% in 2022 and sank 84.29% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $8.6 million in 2022, then slumped by 47.18% to $4.5 million in 2023, then jumped by 172.87% to $12.4 million in 2024, then sank by 84.29% to $1.9 million in 2025, then jumped by 127.1% to $4.4 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $4.4 million in Q1 2026, $1.9 million in Q4 2025, and $2.1 million in Q3 2025.